[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337341-105":59,"doc-detail-337341-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","role-of-yap-signaling-in-regulation-of-programmed-cell-death-and-drug-resistance-in-cancer","Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer","","Although advances in cancer therapy have improved patient outcomes, drug resistance continues to limit durable responses. Programmed cell death (PCD) deregulation is a key contributor to resistance across many cancer therapeutics. Yes-associated protein (YAP) and its paralog TAZ, core downstream effectors of the Hippo pathway, are aberrantly activated in human malignancies. Hippo–YAP signaling regulates cell fate, growth, regeneration, and promotes proliferation, metastasis, and drug resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-yap-signaling-in-regulation-of-programmed-cell-death-and-drug-resistance-in-cancer/337341/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-yap-signaling-in-regulation-of-programmed-cell-death-and-drug-resistance-in-cancer/337341.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is drug resistance still a major challenge in cancer therapy?","Question",{"text":112,"@type":113},"Despite improved prognoses from recent treatment advances, tumors often develop resistance that undermines initial responses. Drug resistance can arise through multiple mechanisms affecting drug availability, growth, DNA damage responses, and metabolism.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does deregulation of programmed cell death relate to therapy resistance?",{"text":117,"@type":113},"Many anticancer agents work by triggering programmed cell death. When PCD signaling is deregulated, cells become less susceptible to diverse cancer therapeutics, leading to resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does the Hippo-YAP pathway play in cancer and resistance?",{"text":121,"@type":113},"YAP and TAZ are downstream effectors of the Hippo pathway and can regulate gene transcription after nuclear translocation. Aberrant activation promotes malignant behaviors including proliferation, metastasis, and drug resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337341,1790168514,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2024; 20(1): 15-28. doi: 10.7150/ijbs.83586  \nReview  \nRole of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer  \nWei Zhou1,2, Adrian Lim1, Mouad Edderkaoui1, Arsen Osipov1, Heshui Wu2􀀍, Qiang Wang1􀀍, Stephen Pandol1􀀍  \n1. Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.  \n2. Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.  \n􀀍 Corresponding authors: Dr. Stephen Pandol (e-mail: [Stephen.Pandol@cshs.org](Stephen.Pandol@cshs.org)), Dr. Heshui Wu (e-mail: [heshuiwu@hust.edu.cn](heshuiwu@hust.edu.cn)) and Dr. Qiang Wang ([e-mail: Qiang.Wang@cshs.org](e-mail: Qiang.Wang@cshs.org)).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [http://ivyspring.com/terms](http://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2023.02.16; Accepted: 2023.09.29; Published: 2024.01.01  \nAbstract  \nAlthough recent advances in cancer treatment significantly improved the prognosis of patients, drug resistance remains a major challenge. Targeting programmed cell death is a major approach of antitumor drug development. Deregulation of programmed cell death (PCD) contributes to resistance to a variety of cancer therapeutics. Yes-associated protein (YAP) and its paralog TAZ, the main downstream effectors of the Hippo pathway, are aberrantly activated in a variety of human malignancies. The Hippo-YAP pathway, which was originally identified in Drosophila, is well conserved in humans and plays a defining role in regulation of cell fate, tissue growth and regeneration. Activation of YAP signaling has emerged as a key mechanism involved in promoting cancer cell proliferation, metastasis, and drug resistance. Understanding the role of YAP/TAZ signaling network in PCD and drug resistance could facilitate the development of effective strategies for cancer therapeutics.  \nKeywords: Programmed cell death, YAP/TAZ, Apoptosis, Ferroptosis, Autophagy, Drug resistance  \nCurrent landscape of cancer therapy and challenge  \nSurgery combined with chemotherapy or radiotherapy are currently the first-line treatment modalities for localized tumors. However, many patients suffer from tumor recurrence and development of acquired resistance despite success in initial treatment [1, 2] . Most patients with advanced solid tumors, such as hepatocellular carcinoma, pancreatic adenocarcinoma and glioblastoma, show intrinsic resistance to chemotherapy and other antitumor agents at the initial stage [3-5] . Drug resistance in cancer is multifaceted and can be mediated by mechanisms that impact on drug availability, cell proliferation and response to DNA damage or metabolic pathways. Deregulation of cell death signaling represents an important mechanism of drug resistance because most of the anti-tumor therapy agents aim to trigger programmed cell death [6] . Thus, understanding the signaling pathways  \ninvolved in regulating PCD and drug resistance can provide insights into development of new therapeutic targets.  \nThe Hippo-YAP signaling pathway  \nThe Hippo-YAP signaling plays an important role in aspects of malignant transformation, including cell proliferation, tumor progression, metastasis, and drug resistance [7-10] . YAP and its paralog TAZ are the main downstream effectors of the Hippo-YAP pathway and act as a transcriptional coactivator [11-13] . The YAP signaling can translocate into the nucleus and mediates gene transcription by binding to transcription factors, such as the TEA domain family (TEAD) proteins [12] . YAP exhibits oncogenic activities [14, 15] and is upregulated in most solid tumors [16-22] . YAP signaling target genes participate in regulation ","cbCaifRThLZBbLfo","https://ap.wps.com/l/cbCaifRThLZBbLfo","pdf",5041047,14,"English","# Abstract\n# Current landscape of cancer therapy and challenge\n# The Hippo-YAP signaling pathway\n# YAP/TAZ and programmed cell death (PCD)\n# YAP/TAZ and drug resistance\n# Therapeutic implications and future perspectives","[{\"question\":\"Why is drug resistance still a major challenge in cancer therapy?\",\"answer\":\"Despite improved prognoses from recent treatment advances, tumors often develop resistance that undermines initial responses. Drug resistance can arise through multiple mechanisms affecting drug availability, growth, DNA damage responses, and metabolism.\"},{\"question\":\"How does deregulation of programmed cell death relate to therapy resistance?\",\"answer\":\"Many anticancer agents work by triggering programmed cell death. When PCD signaling is deregulated, cells become less susceptible to diverse cancer therapeutics, leading to resistance.\"},{\"question\":\"What role does the Hippo-YAP pathway play in cancer and resistance?\",\"answer\":\"YAP and TAZ are downstream effectors of the Hippo pathway and can regulate gene transcription after nuclear translocation. Aberrant activation promotes malignant behaviors including proliferation, metastasis, and drug resistance.\"}]","Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer | PDF",1790018697,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97b8e21093bff4de74df2a1fa732e80b.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4e75de83dc037f25c1aacf311af4d29.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/390007529fcc5b5d80c6a23ead28f9c5.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/568b80bfe819c5e8558081486bae3ca3.webp",980,1268]